Optimizing the Management of IBS-C and Chronic Constipation: From Timely Diagnosis to Effective Treatment

Trending3.5(New)

Irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC) are among the most common functional gastrointestinal disorders encountered in primary care and gastroenterology practice. Although they are rarely life-threatening, they can profoundly affect quality of life, work productivity, emotional wellbeing, sleep, social participation, and healthcare utilization. Many patients experience years of symptoms before receiving an accurate diagnosis, and a substantial proportion remain inadequately controlled despite the use of over-the-counter (OTC) therapies.

7 Modules1 hour
$169$0
Start Learning
Optimizing the Management of IBS-C and Chronic Constipation: From Timely Diagnosis to Effective Treatment

Learning Outcomes

What you'll learn

  • Describe the epidemiology, pathophysiology, and clinical burden of IBS-C and chronic constipation.
  • Differentiate IBS-C from functional chronic constipation using Rome V diagnostic criteria.
  • Identify alarm features that require further investigation or specialist referral.
  • Recognize patients who remain symptomatic despite current management or OTC therapy.
  • Apply evidence-based lifestyle, dietary, and behavioural interventions for constipation-related disorders.
  • Select appropriate pharmacologic therapies based on symptom severity, treatment response, and guideline recommendations.
  • Determine when treatment escalation to prescription therapies is indicated.
  • Counsel patients on realistic expectations, adherence strategies, and long-term management.
  • Integrate gut–brain, psychosocial, and quality-of-life considerations into clinical decision-making.
  • Optimize patient outcomes through timely diagnosis, individualized treatment, and structured follow-up.

Stay updated with our

Healthcare trainingHealthcare training

Training Overview

  • Understanding IBS-C and Chronic Constipation
  • Diagnosis Using Rome V Criteria and Red Flag Assessment
  • Initial Management and Lifestyle Interventions
  • Evidence-Based Pharmacologic Treatment
  • Treatment Escalation, Refractory Symptoms, and Patient Counselling
  • Complex Cases, Integrated Care, and Outcome Optimization
  • Summary
Healthcare trainingHealthcare trainingHealthcare trainingHealthcare trainingHealthcare trainingHealthcare trainingHealthcare training

Top reviews

No reviews yet.

You May Also Like

Take Your
Learning Anywhere

Stay on top of your learning with the Care Learning app.

Download on the App StoreGet it on Google Play

Are you a qualified
Trainer or Instructor?

Join Care Learning as a trainer and deliver high-quality courses to learners across healthcare and workplace training.

Refer a Friend &
Earn Rewards.

Invite healthcare professionals to join Care Learning and get rewarded when your referral successfully joins.

1 / 3

Frequently asked questions

IBS-C is characterized by recurrent abdominal pain associated with bowel habits, whereas functional chronic constipation primarily involves difficult or infrequent bowel movements without the same pain-predominant pattern.

Further evaluation is warranted when alarm features are present, such as weight loss, rectal bleeding, iron deficiency anemia, nocturnal symptoms, new-onset symptoms after age 50, or a family history of colorectal cancer.

Not necessarily. Soluble fibre (psyllium) has the best evidence, while insoluble fibre may worsen bloating and abdominal discomfort in some patients with IBS-C.

Escalation should be considered when patients remain significantly symptomatic despite an adequate trial of lifestyle measures and OTC therapies such as fibre and PEG.

Yes. Dyssynergic defecation is an important cause of refractory constipation and often presents with excessive straining, blockage sensation, and incomplete evacuation.

The goal is meaningful improvement in symptoms, daily functioning, and quality of life, rather than complete elimination of every gastrointestinal symptom.